These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4176573)

  • 1. Experimental neuropathy in rats made diabetic with alloxan.
    Lovelace RE
    Electroencephalogr Clin Neurophysiol; 1968 Oct; 25(4):399. PubMed ID: 4176573
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sharma SS; Sayyed SG
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral neuropathy in the alloxan-diabetic rat.
    Preston GM
    J Physiol; 1967 Apr; 189(2):49P-50P. PubMed ID: 6034119
    [No Abstract]   [Full Text] [Related]  

  • 4. Motor and sensory conduction in peripheral nerves of unanaesthetized streptozotocin diabetic and normal rats during ischemia.
    David J; Wagle GP; Grewal RS
    Indian J Physiol Pharmacol; 1982; 26(1):13-22. PubMed ID: 7106955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
    Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
    Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sayyed SG; Kumar A; Sharma SS
    Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regenerative processes in experimental diabetic neuropathy.
    Eliasson SG
    Trans Am Neurol Assoc; 1965; 90():35-7. PubMed ID: 5857772
    [No Abstract]   [Full Text] [Related]  

  • 8. Distal neuropathy in experimental diabetes mellitus.
    Brown MJ; Sumner AJ; Greene DA; Diamond SM; Asbury AK
    Ann Neurol; 1980 Aug; 8(2):168-78. PubMed ID: 7425570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes.
    Cameron NE; Cotter MA
    Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy.
    Sharma SS; Kumar A; Kaundal RK
    Life Sci; 2008 Mar; 82(11-12):570-6. PubMed ID: 18262571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats.
    Hasegawa T; Kosaki A; Shimizu K; Matsubara H; Mori Y; Masaki H; Toyoda N; Inoue-Shibata M; Nishikawa M; Iwasaka T
    Exp Neurol; 2006 Jun; 199(2):274-80. PubMed ID: 16337192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
    Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition metals and polyol pathway in the development of diabetic neuropathy in rats.
    Nakamura J; Hamada Y; Chaya S; Nakashima E; Naruse K; Kato K; Yasuda Y; Kamiya H; Sakakibara F; Koh N; Hotta N
    Diabetes Metab Res Rev; 2002; 18(5):395-402. PubMed ID: 12397582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T; Nakamura J; Koh N; Sakakibara F; Hamada Y; Sasaki H; Naruse K; Nakashima E; Takeuchi N; Inukai S
    J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ameliorating human diabetic neuropathy: lessons from implanting hematopoietic mononuclear cells.
    Malik RA; Veves A; Tesfaye S
    Exp Neurol; 2006 Sep; 201(1):7-14. PubMed ID: 16808913
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral and autonomic nerve function tests in early diagnosis of diabetic neuropathy: correlation between motor nerve conduction velocity and fasting plasma glucose.
    Zhong XL; Zheng BD; Hu GX; Zhu XX; Zhu WB; Yao JL; Hu ZM
    Chin Med J (Engl); 1981 Aug; 94(8):495-502. PubMed ID: 6791890
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
    Saini AK; Kumar H S A; Sharma SS
    Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy.
    Hoybergs YM; Meert TF
    Neurosci Lett; 2007 May; 417(2):149-54. PubMed ID: 17412508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial in vivo determination of motor conduction velocity in tails of allaxanized non-diabetic and diabetic rats.
    Goto I; Peters HA
    J Neurol Sci; 1974 Jun; 22(2):177-82. PubMed ID: 4829192
    [No Abstract]   [Full Text] [Related]  

  • 20. NERVE CONDUCTION CHANGES IN EXPERIMENTAL DIABETES.
    ELIASSON SG
    J Clin Invest; 1964 Dec; 43(12):2353-8. PubMed ID: 14234831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.